Research shows the contraceptive vaginal ring sold under the brand name NuvaRing causes heart-related side effects, blood clots, and strokes. The Rottenstein Law Group compassionately advocates for those who have suffered from the harmful side effects of potentially dangerous drugs.
If you’ve used NuvaRing and believe it harmed you, contact RLG for a free, confidential legal consultation. We will evaluate your case and remain on the lookout for NuvaRing recalls and NuvaRing class action lawsuits. We might be the NuvaRing law firm you are looking for.
Who Manufactures NuvaRing?
The NuvaRing device was originally developed by Organon, a Dutch pharmaceutical company. Organon received approval from the U.S. Food and Drug Administration (FDA) to sell NuvaRing in the United States on October 3, 2001, and began marketing the device in early 2002. By 2007, 1.5 million women were using NuvaRing worldwide.
In 2007, Schering-Plough purchased Organon, and in 2009 Schering-Plough merged with Merck.
What Is NuvaRing and How Does It Work?
NuvaRing is a flexible plastic (ethylene-vinyl acetate copolymer) ring that a woman can insert into her vagina as a birth control device. Over a three-week time period, it releases low doses of progestin and estrogen hormones.
The ring works by releasing 0.120 mg/day of progestagen (etonogestral) and 0.015 mg/day of estrogen (ethinyl estradiol) during the three-week period it is inside the vagina. Then women take a break week in which they have a normal menstrual period. This break week functions much the same way as the drug-free pills included in standard birth control regimens.
Researchers are testing the effects of extended NuvaRing use by skipping the break week and allowing women to insert a fresh ring back-to-back over the course of a bi-monthly, quarterly, or yearly bases.
NuvaRings are kept in place by vaginal muscles and is rarely expelled accidentally.
NuvaRing’s Potential Side Effects Are Life-Threatening
Caused by the device’s hormones’ impact on users, NuvaRing’s side-effects bear similarities to those caused by traditional combined oral contraceptives, and can be exacerbated by smoking and history of heart problems.
NuvaRing’s side effects are primarily cardiac in nature; they include the following:
- blood clots;
- myocardial infarction;
- pulmonary embolism (PE);
- deep vein thrombosis (DVT);
- heart attack;
- heart arrhythmia;
- gallbladder disease requiring surgery or removal of the gallbladder; and
Women’s bodies metabolize NuvaRing’s etonogestrel into desogestrel, which increases the risk of blood clots by 1.5 to 2.4 times the risk of older oral contraceptives according to two studies published in the New England Journal of Medicine.
Additionally, in May 2012, the British Medical Journal published a meta-analysis of women who were using non-oral hormonal contraceptives (including NuvaRing) based on data contained in four Danish medical registries. The studies focused on 626,158 non-pregnant women between the ages of 15 and 49 who did not have a history of thrombosis or cancer between 2001 and 2010. The researchers determined that vaginal ring use increased the risk of thrombosis by 6.5 times compared to women of the same age who did not use them. The risk corresponded to 7.8 thrombosis events per 10,000 exposure years.
Have Any NuvaRing Lawsuits Been Filed?
NuvaRing’s side effects have not prompted a NuvaRing recall. That will not stop injured parties from filing NuvaRing lawsuits, however. To file a lawsuit for injuries you suffered as a result of product, that product doesn’t have to have been recalled.
People believe Organon misled consumers by minimizing NuvaRing’s warnings on the product’s labeling. A court dismissed the first NuvaRing class action lawsuit without prejudice in 2009, but the plaintiffs joined the ongoing Multidistrict Litigation (MDL) case against Organon. Now, all federal NuvaRing lawsuits are pending in MDL in the U.S. District Court for the Eastern District of Missouri before Judge Rodney Sippel. By the end of 2010, more than 730 people had joined the MDL process. Other state court cases are proceeding as well.
The NuvaRing MDL has moved briskly. By case management order, all discovery was to be concluded by June 24, 2011, and the parties will begin the process of choosing which cases will serve as bellwether trials scheduled to begin in March 2012.
RLG’s Will Make Things Easier
The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a NuvaRing lawsuit on your behalf if necessary.
RLG will also keep you up to date on any NuvaRing class action lawsuits, FDA NuvaRing warnings, and NuvaRing FDA recall announcements.
If you have taken NuvaRing and believe it harmed you, contact RLG today.